Study Involving Aranesp in Chronic Kidney Disease

What we are studying

The purpose of this study is to measure the ability of 2 different ways of dosing a medication to prevent red blood cell transfusions in people with chronic kidney disease who have anemia (low red blood cell count) and are not on dialysis. One way of dosing this medication will be to increase or decrease the dose every month, if needed, to make sure that the hemoglobin level (measure of red blood cells) stays in a narrow range during the study. The other way of dosing the medication during the study will be to give the same dose every month.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • 18 years or older
  • Clinical history of chronic kidney disease

What is involved

  • Randomly placed into one of two groups receiving either a steady dose or changing dose of drug

Compensation

You will be paid $50.00 per clinic visit to reimburse you for expenses related to your participation in this study.

Contact Information

Study Coordinator
Laura Gilliam
Email
lgilliam@wakehealth.edu
Phone
336-716-7754

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.